Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61,992 | 53 | 51.5% |
| Consulting Fee | $30,864 | 21 | 25.6% |
| Travel and Lodging | $15,398 | 66 | 12.8% |
| Food and Beverage | $11,795 | 524 | 9.8% |
| Education | $282.52 | 11 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $96,798 | 225 | $0 (2024) |
| Allergan, Inc. | $16,017 | 78 | $0 (2021) |
| PFIZER INC. | $1,847 | 50 | $0 (2024) |
| ABBVIE INC. | $1,160 | 75 | $0 (2024) |
| Merck Sharp & Dohme LLC | $720.45 | 96 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $631.66 | 19 | $0 (2022) |
| Novo Nordisk Inc | $414.60 | 29 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $253.11 | 9 | $0 (2021) |
| Astellas Pharma US Inc | $252.65 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $192.84 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57,686 | 121 | AstraZeneca Pharmaceuticals LP ($56,785) |
| 2023 | $15,957 | 65 | AstraZeneca Pharmaceuticals LP ($15,401) |
| 2022 | $4,591 | 58 | AstraZeneca Pharmaceuticals LP ($3,826) |
| 2021 | $5,881 | 43 | AstraZeneca Pharmaceuticals LP ($4,530) |
| 2020 | $6,719 | 61 | AstraZeneca Pharmaceuticals LP ($3,849) |
| 2019 | $10,349 | 108 | AstraZeneca Pharmaceuticals LP ($7,659) |
| 2018 | $8,252 | 105 | AstraZeneca Pharmaceuticals LP ($4,669) |
| 2017 | $10,897 | 114 | Allergan Inc. ($9,940) |
All Payment Transactions
675 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: PAIN | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $6.70 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $184.36 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $808.02 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $431.46 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $64.84 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $13.40 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 625 | 1,194 | $184,128 | $75,785 |
| 2022 | 9 | 605 | 1,218 | $177,971 | $73,869 |
| 2021 | 9 | 525 | 1,288 | $145,529 | $60,425 |
| 2020 | 11 | 634 | 1,039 | $148,717 | $63,267 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 173 | 173 | $38,752 | $21,196 | 54.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 274 | $56,992 | $20,181 | 35.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 61 | 416 | $51,584 | $18,322 | 35.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 48 | 178 | $12,994 | $6,152 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 109 | $15,369 | $5,588 | 36.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 22 | $6,974 | $3,235 | 46.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,078 | $787.84 | 73.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $322.96 | 83.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 63 | 441 | $48,784 | $20,003 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 286 | $59,488 | $19,762 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 111 | 111 | $24,864 | $13,802 | 55.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 127 | $17,907 | $7,087 | 39.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 41 | 176 | $12,848 | $6,225 | 48.5% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 23 | 24 | $7,608 | $3,095 | 40.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,777 | $1,937 | 51.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $1,960 | $1,371 | 69.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $735.00 | $586.95 | 79.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 187 | 236 | $49,088 | $18,399 | 37.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 63 | 482 | $31,330 | $13,558 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 68 | 68 | $15,232 | $8,749 | 57.4% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 52 | 274 | $20,002 | $7,353 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 114 | $16,074 | $6,258 | 38.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 17 | 18 | $5,706 | $2,552 | 44.7% |
| 99484 | Care management services for behavioral health conditions, at least 20 minutes clinical staff time | Office | 2021 | 12 | 61 | $5,612 | $2,009 | 35.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 20 | 20 | $1,960 | $1,305 | 66.6% |
About Dr. Henry Naddaf, MD
Dr. Henry Naddaf, MD is a Family Medicine healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679570352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Naddaf, MD has received a total of $120,331 in payments from pharmaceutical and medical device companies, with $57,686 received in 2024. These payments were reported across 675 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($61,992).
As a Medicare-enrolled provider, Naddaf has provided services to 2,389 Medicare beneficiaries, totaling 4,739 services with total Medicare billing of $273,346. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Toledo, OH
- Active Since 07/07/2005
- Last Updated 12/13/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1679570352
Products in Payments
- AIRSUPRA (Drug) $61,481
- FASENRA (Drug) $15,502
- LINZESS (Drug) $12,474
- FASENRA (Biological) $4,480
- UBRELVY (Drug) $3,526
- COLOGUARD (Device) $1,348
- BREZTRI (Drug) $1,255
- FARXIGA (Drug) $903.69
- JANUVIA (Drug) $540.49
- VRAYLAR (Drug) $505.77
- XARELTO (Drug) $504.39
- QULIPTA (Drug) $491.04
- SYMBICORT (Drug) $314.98
- JARDIANCE (Drug) $282.12
- CHANTIX (Drug) $187.30
- Epclusa (Drug) $177.29
- Ozempic (Drug) $171.71
- ELIQUIS (Drug) $162.42
- NURTEC ODT (Drug) $161.98
- VIBERZI (Drug) $150.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Toledo
Philip Lepkowski, Md, MD
Family Medicine — Payments: $34,494
Stacy Bowen, D.o, D.O
Family Medicine — Payments: $27,646
Georges Jabaly, M.d, M.D
Family Medicine — Payments: $20,105
Dr. Darlene Fairchild, Md, MD
Family Medicine — Payments: $14,290
Tanya Baldwin, Md, MD
Family Medicine — Payments: $12,758
Dr. Samina Hasan, Md, MD
Family Medicine — Payments: $12,344